Drug metabolism in dog liver microsomes assessed as 2-(3,4-Dimethoxybenzyl)-5-methyl-7-((2R,3R)-2,5,6-trihydroxy-6-phenylhexan-3-yl)imidazo[5,1-f ][1,...

Basic Information

ID: ALA4049164

Type: ADME

Description: Drug metabolism in dog liver microsomes assessed as 2-(3,4-Dimethoxybenzyl)-5-methyl-7-((2R,3R)-2,5,6-trihydroxy-6-phenylhexan-3-yl)imidazo[5,1-f ][1,2,4]triazin-4(3H)-one formation at 20 uM after 1 hr by UHPLC-UV-HRMS method

Format: BAO_0000019

Organism: Canis lupus familiaris

Tissue: Liver

Subcellular Fraction: microsome

Target: Liver(ALA613430)

Document: ALA4043302

Drug metabolism in dog liver microsomes assessed as 2-(3,4-Dimethoxybenzyl)-5-methyl-7-((2R,3R)-2,5,6-trihydroxy-6-phenylhexan-3-yl)imidazo[5,1-f ][1,2,4]triazin-4(3H)-one formation at 20 uM after 1 hr by UHPLC-UV-HRMS method: 1

Associated Items: Associated Bioactivities Associated Compounds

Activity Charts

Bioactivity

Activity Types for Assay ALA4049164

Drug metabolism

Total(1)

Parent Molecular Weight	ALogP	Polar Surface Area
476.58	4.23	4.23

Parent Molecular Weight

ALogP

Polar Surface Area

476.58

4.23

Drug metabolism in dog liver microsomes assessed as 2-(3,4-Dimethoxybenzyl)-5-methyl-7-((2R,3R)-2,5,6-trihydroxy-6-phenylhexan-3-yl)imidazo[5,1-f ][1,...

Basic Information

Activity Charts

Compound Summary